JP2007126441A5 - - Google Patents

Download PDF

Info

Publication number
JP2007126441A5
JP2007126441A5 JP2006266214A JP2006266214A JP2007126441A5 JP 2007126441 A5 JP2007126441 A5 JP 2007126441A5 JP 2006266214 A JP2006266214 A JP 2006266214A JP 2006266214 A JP2006266214 A JP 2006266214A JP 2007126441 A5 JP2007126441 A5 JP 2007126441A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
loxoprofen
composition according
fudostein
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006266214A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007126441A (ja
JP5095169B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2006266214A priority Critical patent/JP5095169B2/ja
Priority claimed from JP2006266214A external-priority patent/JP5095169B2/ja
Publication of JP2007126441A publication Critical patent/JP2007126441A/ja
Publication of JP2007126441A5 publication Critical patent/JP2007126441A5/ja
Application granted granted Critical
Publication of JP5095169B2 publication Critical patent/JP5095169B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2006266214A 2005-10-03 2006-09-29 杯細胞過形成抑制のための医薬組成物 Active JP5095169B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006266214A JP5095169B2 (ja) 2005-10-03 2006-09-29 杯細胞過形成抑制のための医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005289520 2005-10-03
JP2005289520 2005-10-03
JP2006266214A JP5095169B2 (ja) 2005-10-03 2006-09-29 杯細胞過形成抑制のための医薬組成物

Publications (3)

Publication Number Publication Date
JP2007126441A JP2007126441A (ja) 2007-05-24
JP2007126441A5 true JP2007126441A5 (es) 2009-10-08
JP5095169B2 JP5095169B2 (ja) 2012-12-12

Family

ID=38149387

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006266214A Active JP5095169B2 (ja) 2005-10-03 2006-09-29 杯細胞過形成抑制のための医薬組成物

Country Status (1)

Country Link
JP (1) JP5095169B2 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001199882A (ja) * 2000-01-20 2001-07-24 Taisho Pharmaceut Co Ltd 感冒・鼻炎用組成物
EP1391201A4 (en) * 2001-05-25 2004-06-30 Ssp Co Ltd MEDICAL COMPOSITIONS
JP2003095978A (ja) * 2001-09-27 2003-04-03 Takeda Chem Ind Ltd 鎮咳去痰用医薬組成物
JP4585220B2 (ja) * 2003-04-09 2010-11-24 第一三共株式会社 ロキソプロフェン含有経口用組成物

Similar Documents

Publication Publication Date Title
JP2007314517A5 (es)
IL203747A (en) Use of a steroid sex precursor in the manufacture of a 13mg dose or less for daily dosing through the vagina to treat vaginal diseases and a vaginal pharmacological preparation containing it
NZ593199A (en) Milnacipran for the long-term treatment of fybromyalgia syndrome
CL2013001136A1 (es) Un agente inhibitorio de la fosfodiesterasa 7 (pde7) para ser usado en el tratamiento o la reduccion de la posibilidad de una adiccion; y composicion farmaceutica, forma de dosificacion unitaria y kit farmaceutico que incluyen al inhibidor de fosfodiesterasa 7 (pde7) y un agente terapeutico adicional.
BRPI0906181A2 (pt) "método para tratamento de uma disfunção hiperproliferativa, composição farmacêutica, uso de uma combinação terapêutica na fabricação de um medicamento para o tratamento de câncer, artigo de fabricação para tratamento de uma disfunção hiperproliferativa, método para determinação de compostos a serem usados em combinação para o tratamento de câncer e método para determinação de uma combinação terapêutica a ser usada para o tratamento de câncer"
NZ623495A (en) Oral formulations of cytidine analogs and methods of use thereof
BRPI0507966A (pt) uso de meloxicam para o tratamento de doenças respiratórias em porcos
IL193099A (en) Use of ferric citrate-containing preparations in the preparation of chronic kidney disease drugs
MX2009003372A (es) Formas de dosificacion de pelicula no mucoadhesiva.
JP2014532704A5 (es)
CL2007003635A1 (es) Compuestos derivados de 6-amino-purin-8-ona; proceso de preparacion; composicion farmaceutica; proceso para preparar la composicion farmaceutica; y uso en el tratamiento de enfermedades alergicas, virales o cancer.
HK1129844A1 (en) Use of l-cytosine nucleoside analogs in the manufacture of a medicament for use in treating cancer and other conditions or disease states l-
PE20142319A1 (es) Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero
RS52867B (en) GLATIRAMER ACETATOM AND RAZAGILIN COMBINED THERAPY FOR MULTIPLE SCLEROSIS
JP2009516719A5 (es)
CL2007003472A1 (es) Sal fumarato de (alfa s,beta r)-6-bromo-alfa-[2-(dimetilamino)etil]-2-metoxi-alfa-1-naftalenil-beta-fenil-3-quinolinaetanol; proceso de preparacion; composicion farmaceutica; proceso de preparacion de la composicion farmaceutica; y uso en el tratamie
MX2009006327A (es) Compuestos heterociclicos y metodos de uso de los mismos.
BRPI0815203B8 (pt) composição em gel contendo pirfenidona, e seu processo de fabricação
UA110463C2 (ru) ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ 4-{[9-ХЛОР-7-(2-ФТОР-6-МЕТОКСИФЕНІЛ)-5Н-ПІРИМІДО[5,4-d][2]БЕНЗАЗЕПІН-2-ІЛ]АМІНО}-2-МЕТОКСИБЕНЗОЙНОЇ КИСЛОТИ ДЛЯ ЛІКУВАННЯ РАКУ Й ІНШИХ ЗАХВОРЮВАНЬ І ПОРУШЕНЬ СТАНУ ЗДОРОВ'Я
JP2008013542A5 (es)
IL198180A (en) Salt p- toluene 5-amino-3-sulfonic acid (2'-0-acetyl-3'-deoxy-ß-d-riboforanosyl) -3h-thiazole [5,4- d] pyrimidine-2-on crystalline form , A pharmaceutical product containing it, its use in the preparation of a drug and methods for its manufacture
JP2008110970A5 (es)
JP2005507892A5 (es)
TNSN08506A1 (en) Substituted carboxamides
JP2007119497A5 (es)